Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Osteoporosis

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 25 articles: HTML format

Single Articles

July 2021
1. IKPEZE T, Andrews N
   Comminuted Lumbar Vertebral Fracture.
   N Engl J Med. 2021;385:264.
   PubMed    
   
   
   November 2020
2. BLACK DM, Eastell R, Adams AL
   Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates. Reply.
   N Engl J Med. 2020;383:2189-2190.
   PubMed    
   
   
   
3. GARTON M
   Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
   N Engl J Med. 2020;383:2189.
   PubMed    
   
   
   
4. OTT SM, Heckbert SR
   Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
   N Engl J Med. 2020;383:2188-2189.
   PubMed    
   
   
   
5. UEDA M, Kami M
   Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
   N Engl J Med. 2020;383:2188.
   PubMed    
   
   
   August 2020
6. BLACK DM, Geiger EJ, Eastell R, Vittinghoff E, et al
   Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.
   N Engl J Med. 2020;383:743-753.
   PubMed     Abstract available
   
   
   April 2019
7. HUMPHREY MB, Buckley L
   Glucocorticoid-Induced Osteoporosis. Reply.
   N Engl J Med. 2019;380:1379.
   PubMed    
   
   
   
8. SOSA M, Gomez de Tejada MJ
   Glucocorticoid-Induced Osteoporosis.
   N Engl J Med. 2019;380:1378-1379.
   PubMed    
   
   
   December 2018
9. BUCKLEY L, Humphrey MB
   Glucocorticoid-Induced Osteoporosis.
   N Engl J Med. 2018;379:2547-2556.
   PubMed    
   
   
   March 2018
10. GOLLOGLY L, Norris S, Ford N
    Correcting the Record on a Fracture Risk Assessment Tool.
    N Engl J Med. 2018;378:867-868.
    PubMed    
    
    
    January 2018
11. 
    Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.
    N Engl J Med. 2018;378:194-196.
    PubMed    
    
    
    
12. TSOURDI E, Rachner TD, Hofbauer LC
    Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.
    N Engl J Med. 2018;378:195.
    PubMed    
    
    
    
13. LEWIS JR, Schousboe JT, Prince RL
    Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.
    N Engl J Med. 2018;378:194-5.
    PubMed    
    
    
    
14. SONG GG, Lee YH
    Romosozumab versus Alendronate and Fracture Risk in Women with Osteoporosis.
    N Engl J Med. 2018;378:194.
    PubMed    
    
    
    October 2017
15. ROSEN CJ
    Romosozumab - Promising or Practice Changing?
    N Engl J Med. 2017;377:1479-1480.
    PubMed    
    
    
    September 2017
16. SAAG KG, Petersen J, Brandi ML, Karaplis AC, et al
    Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis.
    N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1708322.
    PubMed     Abstract available
    
    
    May 2017
17. ROCA-AYATS N, Balcells S, Garcia-Giralt N, Falco-Mascaro M, et al
    GGPS1 Mutation and Atypical Femoral Fractures with Bisphosphonates.
    N Engl J Med. 2017;376:1794-1795.
    PubMed    
    
    
    January 2017
18. KALYAN SH
    Romosozumab Treatment in Postmenopausal Osteoporosis.
    N Engl J Med. 2017;376:395-6.
    PubMed    
    
    
    
19. BANHIDY NF, MacKinnon TS, Banhidy FP
    Romosozumab Treatment in Postmenopausal Osteoporosis.
    N Engl J Med. 2017;376:395.
    PubMed    
    
    
    
20. SHARMA R, Torka P
    Romosozumab Treatment in Postmenopausal Osteoporosis.
    N Engl J Med. 2017;376:395.
    PubMed    
    
    
    
21. KRANENBURG G, Bartstra JW, de Jong PA
    Romosozumab Treatment in Postmenopausal Osteoporosis.
    N Engl J Med. 2017;376:396.
    PubMed    
    
    
    
22. 
    Romosozumab Treatment in Postmenopausal Osteoporosis.
    N Engl J Med. 2017;376:396-7.
    PubMed    
    
    
    September 2016
23. ROSEN CJ, Ingelfinger JR
    Building Better Bones with Biologics - A New Approach to Osteoporosis?
    N Engl J Med. 2016.
    PubMed    
    
    
    
24. COSMAN F, Crittenden DB, Adachi JD, Binkley N, et al
    Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
    N Engl J Med. 2016.
    PubMed     Abstract available
    
    
    May 2016
25. 
    Postmenopausal Osteoporosis.
    N Engl J Med. 2016;374:1797.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: